Navigation Links
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Date:1/26/2009

,097 Other non-current liabilities 1,765 934 Stockholders' equity 20,386 17,869 ------ ------ Total liabilities and stockholders' equity $36,443 $34,639 ======= ======= Shares outstanding 1,047 1,087 Amgen Inc. Reconciliation of "Adjusted" Earnings Per Share Guidance to GAAP Earnings Per Share Guidance for the Year Ending December 31, 2009 (Unaudited) 2009 ---- "Adjusted" earnings per share guidance $4.55 - $4.75 Known adjustments to arrive at GAAP earnings: Amortization of acquired intangible assets, product technology rights (a) (0.17) Incremental non-cash interest expense (b) (0.14) - (0.16) Stock option expense (c) (0.06) - (0.08) Restructuring costs (d) (0.03) - (0.06) Amortization of acquired intangible assets, R&D technology rights (e) (0.04) ----- ----- GAAP earnings per share guidance $4.04 - $4.31 ===== ===== (a) To exclude the ongoing, non-cash amortization of acquired product technology rights, primarily ENBREL, related to the Immunex acquisition. (b) To exclude the estimated impact of the incremental non-cash interest expense related to our outstanding convertible debt resulting fr
'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
2. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
3. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
6. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
7. Martek Announces Fourth Quarter and FY 2008 Financial Results
8. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
11. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
(Date:12/19/2014)... -- Naurex Inc., a biopharmaceutical company leveraging its unique ... central nervous system, today announced that Norbert Riedel ... at the 33 rd annual J.P. Morgan Healthcare ... p.m. PST on Tuesday, January 13, 2015, at the ... About Naurex Inc. ...
(Date:12/19/2014)... CITY, Calif. , Dec. 19, 2014 Bina ... , USA) announced today that they have been acquired ... 1,2 is a privately held company that provides ... of next generation sequencing (NGS) data for the academic ... the Roche Sequencing Unit, and will continue to focus ...
(Date:12/19/2014)... , Dec. 19, 2014 Research and Markets ... addition of the "Technology Innovations in Smart ... http://photos.prnewswire.com/prnh/20130307/600769 ... Smart Fabrics" offers a detailed assessment on technological ... Key Findings: 1. The Smart ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Innovations in Smart Fabrics (Technical Insights) 2
... 28 CardioDynamics (Nasdaq:,CDIC), the innovator and leader ... Company has received market clearance from,the U.S. Food ... parameters,and electronic medical record (EMR) interface capability for ... product of a co-development partnership between,the Company and ...
... to Sequence Entire Human Genome in Eight Hours at a Cost of ... ... PHILADELPHIA, and MOUNTAIN VIEW, Calif., Sept. 27 ,BioNanomatrix, Inc., a company ... (CGI), a,high- performance genome sequencing company, today announced that they have,formed a ...
... Leading Pharmaceutical Companies Slated to ... ... Board: PHST), a leading provider of software and,strategic services for optimizing clinical ... (PKS(TM)) User Group Meeting on October 3 and 4, 2007 at the,Marriott ...
Cached Biology Technology:CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility 2CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility 3BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome 2BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome 3Pharsight Hosts Fourth Annual PKS User Group Meeting 2Pharsight Hosts Fourth Annual PKS User Group Meeting 3
(Date:12/17/2014)... , Dec. 15, 2014 The ... make it easier to detect and prevent counterfeit ... Today the agency started performing an in-house ... will validate the authenticity of purchased microcircuits while ... new quality control measures will be conducted at ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ... 2015-2019"  report to their offering. ... advances in technology. With continuous advances in technology, ... the latest standard that meets the needs and ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... KAN. -- Most of us hate to find the red ... pantries. But for several scientists at Kansas State University, and ... and grain products is the best organism for studying genetics. ... an experimental system is largely because of the work of ...
... Tufts University,s Center for Scientific Visualization is enabling ... concepts into clearer, more precise 3-dimensional images than ... by a $350,000 grant from the National Science ... offers a combination of advanced features found nowhere ...
... patch" into early stage fish embryos, researchers at Washington ... to correct a genetic mutation so the embryos developed ... of up to one-fifth of birth defects in humans ... Erik C. Madsen, first author and an M.D./Ph.D. student ...
Cached Biology News:Visual technology enables brain to learn in new ways 2Visual technology enables brain to learn in new ways 3Visual technology enables brain to learn in new ways 4Deadly genetic disease prevented before birth in zebrafish 2Deadly genetic disease prevented before birth in zebrafish 3
Bovine Renal Artery Endothelial Cells (BRAEC) (>500,000 cells)...
RECK (F-20)...
... Rabbit polyclonal to Peroxiredoxin 1 ... peroxidase family, whose mammalian members have ... proliferation, differentiation, and apoptosis. Many isoforms ... to the amino acid sequence homology, ...
... Rabbit polyclonal to beta Synuclein Synucleins ... neural tissue and in certain tumors. The ... beta synuclein, and gamma synuclein. The alpha ... in brain tissue, where they are seen ...
Biology Products: